| 000 | 00842 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513112034.0 | ||
| 264 | 0 | _c19970312 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.410410223 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLees, A J | |
| 245 | 0 | 0 |
_aSelegiline and mortality in Parkinson's disease: another view. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cFeb 1997 |
||
| 300 |
_a282-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aSelegiline _xtherapeutic use |
| 700 | 1 | _aHead, J | |
| 700 | 1 | _aShlomo, Y B | |
| 773 | 0 |
_tAnnals of neurology _gvol. 41 _gno. 2 _gp. 282-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.410410223 _zAvailable from publisher's website |
| 999 |
_c9018610 _d9018610 |
||